Conformational selection in silico: Loop latching motions and ligand binding in enzymes

Proteins: Structure, Function and Genetics

Volumn 71, Issue 1, 2008, Pages 153-164

  Wong, Sergio ^a   Jacobson, Matthew P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Docking; Enzyme substrate recognition; Induced fit; Molecular dynamics

Indexed keywords

ENOLASE; LIGAND; PROTEIN TYROSINE PHOSPHATASE; SOLVENT; SPERMIDINE SYNTHASE; TRIOSEPHOSPHATE ISOMERASE;

ALGORITHM; ARTICLE; COMPUTER MODEL; ENZYME BINDING; ENZYME CONFORMATION; LIGAND BINDING; MOLECULAR DYNAMICS; MOTION; PREDICTION; PRIORITY JOURNAL; PROTEIN STRUCTURE;

ALGORITHMS; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; ENZYMES; LIGANDS; MOTION; PROTEIN BINDING; PROTEIN CONFORMATION;

EID: 40549107133     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21666     Document Type: Article

References (83)

1. Koshland D. Application of a theory of enzyme specificity to protein synthesis. Proc Natl Acad Sci USA 1958;44:98-104.
2. Ma BY, Kumar S, Tsai CJ, Nussinov R. Folding funnels and binding mechanisms. Protein Eng 1999;12:713-720.
3. Tsai CJ, Kumar S, Ma BY, Nussinov R. Folding funnels, binding funnels, and protein function. Protein Sci 1999;8:1181-1190.
4. Tsai CJ, Ma BY, Sham YY, Kumar S, Nussinov R. Structured disorder and conformational selection. Proteins: Struct Funct Genet 2001;44:418-427.
5. Freire E. Statistical thermodynamic linkage between conformational and binding equilibria. Adv Protein Chem 1998;51:255-279.
6. Foote J, Milstein C. Conformational isomerism and the diversity of antibodies. Proc Natl Acad Sci USA 1994;91:10370-10374.
7. James LC, Tawfik DS. Structure and kinetics of a transient antibody binding intermediate reveal a kinetic discrimination mechanism in antigen recognition. Proc Natl Acad Sci USA 2005;102:12730-12735.
8. Berger C, Weber-Bornhauser S, Eggenberger J, Hanes J, Pluckthun A, Bosshard H. Antigen recognition by conformational selection. FEBS Lett 1999;450:149-153.
9. Aparicio R, Ferreira ST, Polikarpov I. Closed conformation of the active site loop of rabbit muscle triosephosphate isomerase in the absence of substrate: evidence of conformational heterogeneity. J Mol Biol 2003;334:1023-1041.
10. Williams JC, Mcdermott AE. Dynamics of the flexible loop of triosephosphate isomerase: the loop motion is not ligand-gated. Biochemistry 1995;34:8309-8319.
11. Alvarez M, Zeelen J, Mainfroid V, Rentier-Delrue F, Martial J, Wyns L, Wierenga R, Maes D. Triose-phosphate isomerase (TIM) of the psychrophilic bacterium Vibrio marinus. J Biol Chem 1998;273:2199-2206.
12. Mande S, Mainfroid V, Kalk K, Martial J, Hol W. Crystal structure of recombinant human triosephosphate isomerase at 2.8 Å resolution. Triosephophate isomerase-related human genetic disorders and comparison with the trypanosomal enzyme. Proteins 1994;3:810-821.
13. Teague SJ. Implications of protein flexibility for drug discovery. Nat Rev Drug Discov 2003;2:527-541.
14. Wong CF, McCammon JA. Protein flexibility and computer-aided drug design. Annu Rev Pharmacol Toxicol 2003;43:31-45.
15. Carlson HA. Protein flexibility and drug design: how to hit a moving target. Curr Opin Chem Biol 2002;6:447-452.
16. Teodoro M, Kavraki L. Conformational flexibility models for the receptor in structure based drug design. Curr Pharm Des 2003;9:1635-1648.
17. Claussen H, Buning C, Rarey M, Lengauer T. FlexE: efficient molecular docking considering protein structure variations. J Mol Biol 2001;308:377-395.
18. Totrov M, Abagyan R. Flexible protein-ligand docking by global energy optimization in internal coordinates. Proteins 1997; (Suppl 1):215-220.
19. Taylor R, Jewsbury P, Essex J. FDS: flexible ligand and receptor docking with a continuum solvent model and soft-core energy function. J Comput Chem 2003;24:1637-1656.
20. Sherman W, Day T, Jacobson MP, Friesner RA, Farid R. Novel procedure for modeling ligand/receptor induced fit effects. J Med Chem 2006;49:534-553.
21. Masukawa KM, Carlson HA, McCammon JA. Technique for developing a pharmacophore model that accommodates inherent protein flexibility: an application to HIV-1 integrase. In: Guner OF, editor. Pharmacophore perception, development and use in drug design. La Jolla, CA: International University Line; 2000. p 537.
22. Lin JH, Perryman AL, Schames JR, McCammon JA. The relaxed complex method: accommodating receptor flexibility for drug design with an improved scoring scheme. Biopolymers 2003;68:47-62.
23. Frembgen-Kesner T, Elcock A. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase. J Mol Biol 2006;359:202-214.
24. Wong CF, Kua J, Zhang Y, Straatsma TP, McCammon JA. Molecular docking of balanol to dynamics snapshots of protein kinase A. Proteins 2005;61:850-858.
25. Alonso A, Bliznyuk A, Gready J. Combining docking and molecular dynamic simulations in drug design. Med Res Rev 2006;26:531-568.
26. Ikeguchi M, Ueno J, Sato M, Kidera A. Protein structural change upon ligand binding: linear response theory. Phys Rev Lett 2005;94:078102.
27. Cavasotto CN, Kovacs JA, Abagyan RA. Representing receptor flexibility in ligand docking through relevant normal modes. J Am Chem Soc 2005;127:9632-9640.
28. Cao Y, Musah RA, Wilcox SK, Goodin DB, McRee DE. Protein conformer selection by ligand binding observed with crystallography. Protein Sci 1998;7:72-78.
29. Juszczak LJ, Zhang ZY, Wu L, Gottfried DS, Eads DD. Rapid loop dynamics of Yersinia protein tyrosine phosphatases. Biochemistry 1997;36:2227-2236.
30. Meagher KL, Carlson HA. Incorporating protein flexibility in structure-based drug discovery: using HIV-1 protease as a test case. J Am Chem Soc 2004;126:13276-13281.
31. Babbitt PC, Mrachko GT, Hasson MS, Huisman GW, Kolter R, Ringe D, Petsko GA, Kenyon GL, Gerlt JA. Functionally diverse enzyme superfamily that abstracts the α-protons of carboxylic-acids. Science 1995;267:1159-1161.
32. Gulick AM, Schmidt DMZ, Gerlt JA, Rayment I. Evolution of enzymatic activities in the enolase superfamily: crystal structures of the L-Ala-D/L-Glu epimerases from Escherichia coli and Bacillus subtilis. Biochemistry 2001;40:15716-15724.
33. Klenchin VA, Schmidt DM, Gerlt JA, Rayment I. Evolution of enzymatic activities in the enolase superfamily: structure of a substrate-liganded complex of the L-Ala-D/L-Glu epimerase from Bacillus subtilis. Biochemistry 2004;43:10370-10378.
34. 2+)-complex of yeast enolase and the intermediate analog phosphonoacetohydroxamate at 2.1 Å resolution. Biochemistry 1994;33:9333-9342.
35. McMillan FM, Cahoon M, White A, Hedstrom L, Petsko GA, Ringe D. Crystal structure at 2.4 Å resolution of Borrelia burgdorferi inosine 5′-monophosphate dehydrogenase: evidence of a substrate-induced hinged-lid motion by loop 6. Biochemistry 2000;39:4533-4542.
36. Gerstein M, Chothia C. Analysis of protein loop closure. Two types of hinges produce one motion in lactate-dehydrogenase. J Mol Biol 1991;220:133-149.
37. Wu MG, Deem MW. Efficient Monte Carlo methods for cyclic peptides. Mol Phys 1999;97:559-580.
38. Taylor JC, Markham GD. Conformational dynamics of the active site loop of S-adenosylmethionine synthetase illuminated by site-directed spin labeling. Arch Biochem Biophys 2003;415:164-171.
39. Okoniewska M, Tanaka T, Yada RY. The pepsin residue glycine-76 contributes to active-site loop flexibility and participates in catalysis. Biochem J 2000;349:169-177.
40. Gunasekaran K, Ma BY, Ramakrishnan B, Qasba PK, Nussinov R. Interdependence of backbone flexibility, residue conservation, and enzyme function: a case study on 1,4-galactosyltransferase-I. Biochemistry 2003;42:3674-3687.
41. Dahms TES, Sainz G, Giroux EL, Caperelli CA, Smith JL. The apo and ternary complex structures of a chemotherapeutic target: human glycinamide ribonucleotide transformylase. Biochemistry 2005;44:9841-9850.
42. Rhee S, Parris KD, Hyde CC, Ahmed SA, Miles EW, Davies DR. Crystal structures of a mutant (β K87T) tryptophan synthase α(2)β(2) complex with ligands bound to the active sites of the α-and β-subunits reveal ligand-induced conformational changes. Biochemistry 1997;36:7664-7680.
43. Taylor TC, Andersson I. The structure of the complex between rubisco and its natural substrate ribulose 1,5-bisphosphate. J Mol Biol 1997;265:432-444.
44. Zhang ZY. Protein tyrosine phosphatases: prospects for therapeutics. Curr Opin Chem Biol 2001;5:416-423.
45. Tonks NK. PTP1B: from the sidelines to the front lines! FEBS Lett 2003;546:140-148.
46. Franklin TJ, Morris WP, Jacobs VN, Culbert EJ, Heys CA, Ward WHJ, Cook PN, Jung F, Ple P. A novel series of non-nucleoside inhibitors of inosine 5′-monophosphate dehydrogenase with immunosuppressive activity. Biochem Pharmacol 1999;58:867-876.
47. Pankiewicz KW, Lesiak-Watanabe KB, Watanabe KA, Patterson SE, Jayaram HN, Yalowitz JA, Miller MD, Seidman M, Majumdar A, Prehna G, Goldstein BM. Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia. J Med Chem 2002;45:703-712.
48. Haider N, Eschbach ML, Dias SD, Gilberger TW, Walter RD, Luersen K. The spermidine synthase of the malaria parasite Plasmodium falciparum: molecular and biochemical characterisation of the polyamine synthesis enzyme. Mol Biochem Parasitol 2005;142:224-236.
49. Thomas T, Thomas TJ. Polyamine metabolism and cancer. J Cell Mol Med 2003;7:113-126.
50. Kalyanaraman C, Bernacki K, Jacobson MP. Virtual screening against highly charged active sites: identifying substrates of αβ barrel enzymes. Biochemistry 2005;44:2059-2071.
51. Tricot GJ, Jayaram HN, Lapis E, Natsumeda Y, Nichols CR, Kneebone P, Heerema N, Weber G, Hoffman R. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5′-phosphate dehydrogenase-activity. Cancer Res 1989;49:3696-3701.
52. Kovacs JA, Cavasotto CN, Abagyan R. Conformational sampling of protein flexibility in generalized coordinates: application to ligand docking. J Comput Theor Nanosci 2005;2:354-361.
53. Sandak B, Wolfson HJ, Nussinov R. Flexible docking allowing induced fit in proteins: insights from an open to closed conformational isomers. Proteins: Struct Funct Genet 1998;32:159-174.
54. Sugita Y, Okamoto Y. Replica-exchange molecular dynamics method for protein folding. Chem Phys Lett 1999;314:141-151.
55. Mitsutake A, Sugita Y, Okamoto Y. Generalized-ensemble algorithms for molecular simulations of biopolymers. Biopolymers 2001;60:96-123.
56. Stuckey J, Schubert H, Fauman E, Zhang Z, Dixon J, Saper M. Crystal structure of Yersinia protein tyrosin phosphatase at 2.5 Å and the complex with tungstate. Nature 1994;370:571-575.
57. Almassy R, Janson C, Kan C, Hostomska Z. Structures of apo and complexed Escherichia coli glycinamide ribonucleotide transformylase. Proc Natl Acad Sci USA 1992;89:6114-6118.
58. Kobayashi M, Watanabe T, Xu YJ, Tatemori M, Goda H, Niitsu M, Shirahata A, Samejima K. Control of spermidine and spermine levels in rat tissues by trans-4-methylcyclohexylamine, a spermidine-synthase inhibitor. Biol Pharm Bull 2005;28:569-573.
59. Korolev S, Ikeguchi Y, Skarina T, Beasley S, Arrowsmith C, Edwards A, Joachimiak A, Pegg A, Savchenko A. The crystal structure of spermidine synthase wih a multisubstrate adduct inhibitor. Nat Struct Biol 2002;9:27-31.
60. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The protein data bank. Nucleic Acids Res 2000;28:235-242.
61. Delano WL. The PyMOL molecular graphics system. San Carlos, CA: DeLano Scientific; 2002.
62. Case DA, Darden TA, Cheatham TE, III, Simmerling LL, Wang J, Duke RE, Luo R, Merz KM, Wang B, Pearlman DA, Crowley M, Brozell S, Tsui V, Gohlke H, Hornak J, Cui G, Beroza P, Schafmeister C, Caldwell JW, Ross WS, Kollman PA. AMBER 8; University of California, San Francisco, CA, 2004.
63. Simmerling C, Strockbine B, Roitberg AE. All-atom structure prediction and folding simulations of a stable protein. J Am Chem Soc 2002;124:11258-11259.
64. Onufriev A, Bashford D, Case DA. Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins: Struct Funct Bioinf 2004;55:383-394.
65. Berendsen HJC, Postma JPM, Vangunsteren WF, Dinola A, Haak JR. Molecular-dynamics with coupling to an external bath. J Chem Phys 1984;81:3684-3690.
66. Pastor RW, Brooks BR, Szabo A. An analysis of the accuracy of langevin and molecular-dynamics algorithms. Mol Phys 1988;65:1409-1419.
67. Loncharich RJ, Brooks BR, Pastor RW. Langevin dynamics of peptides - the frictional dependence of isomerization rates of N-acetylalanyl- N′-methylamide. Biopolymers 1992;32:523-535.
68. Tuckerman ME, Berne BJ, Rossi A. Molecular-dynamics algorithm for multiple time scales - systems with disparate masses. J Chem Phys 1991;94:1465-1469.
69. Metropolis N, Rosembluth A, Rosembluth M, Teller A. Equation of state calculations by fast computing machines. J Chem Phys 1953;21:1087-1092.
70. Feig M, Karanicolas J, Brooks III CL, MMTB Tool Set: enhanced sampling and multiscale modeling methods for applications in structural biology. J Mol Graph Model 2004;22:337-395.
71. Xu S, Kamath MV, Capson DW. Selection of partitions from a hierarchy. Pattern Recognit Lett 1993;14:7-15.
72. Jacobson MP, Pincus DL, Rapp CS, Day TJF, Honig B, Shaw DE, Friesner RA. A hierarchical approach to all-atom protein loop prediction. Proteins 2004;55:351-367.
73. Jorgensen WL, Tiradorives J. The OPLS potential functions for proteins - energy minimizations for crystals of cyclic-peptides and crambin. J Am Chem Soc 1988;110:1666-1671.
74. Feig M, Onufriev A, Lee MS, Im W, Case DA, Brooks CL. Performance comparison of generalized born and Poisson methods in the calculation of electrostatic solvation energies for protein structures. J Comput Chem 2004;25:265-284.
75. Gallicchio E, Zhang L, Levy R. The SGB/NP hydration free energy model based on the surface generalized born solvent reaction field and novel nonpolar hydration free energy estimators. J Comput Chem 2002;23:517-529.
76. Schrodinger Inc. GLIDE. New York: Schrodinger Inc; 2004.
77. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000;28:27-30.
78. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, Katayama T, Araki M, Hirakawa M. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 2006;34:D354-D357.
79. Coutsias E, Seok C, Jacobson MP, Dill K. A kinematic view of loop closure. J Comput Chem 2004;25:510-528.
80. Lee A, Streinu H, Brock O. A methodology for efficiently sampling the conformational space of molecular structures. Phys Biol 2005;2:s118-s125.
81. Carlson HA. Protein flexibility is an important component of structure-based drug design. Curr Pharm Des 2002;8:1571-1578.
82. Wei B, Weaver L, Ferrari A, Matthews B, Shoichet B. Testing a flexible-receptor docking algorithm in a model binding site. J Mol Biol 2004;337:1161-1182.
83. Huang S, Zou X. Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking. Proteins 2007;66:399-421.